Loading clinical trials...
Loading clinical trials...
Primary hyperparathyroidism is a significant medical and public health problem in the world and affects approximately 100,000 new patients in the United States alone. If left untreated this can lead t...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Pennsylvania
NCT03039439 · Parathyroid Gland Adenoma, Parathyroid Gland Atypical Adenoma, and more
NCT06523582 · Neuroendocrine Neoplasm, Neuroendocrine Neoplasm of Gastrointestinal Tract, and more
NCT05761743 · Primary Hyperparathyroidism, Type 2 Diabetes
NCT01087619 · Primary Hyperparathyroidism
NCT07444723 · Primary Hyperparathyroidism, Parathyroid Cancer, and more
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions